WG
ABBV icon

Winchester Group’s AbbVie ABBV Stock Holding History

Winchester Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$1.99M Sell
44,495
-37,250
-46% -$1.65M 0.44% 65
2013
Q2 		$3.38M Buy
+81,745
New +$3.58M 0.72% 39

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Winchester Group's ABBV Position: Q3 2013 in Review

Winchester Group reduced its AbbVie (ABBV) stake by 46% in Q3 2013, selling an estimated $1.65M and leaving 44,495 shares worth $1.99M. The position accounts for 0.44% of the portfolio, ranked #65.

Winchester Group first reported a position in ABBV in Q2 2013 and has held it in 2 quarters since. The position peaked at $3.38M in Q2 2013. 1,297 funds tracked by Wall St. Rank hold ABBV as of Q3 2013.

  • Winchester Group held 44,495 shares of AbbVie worth $1.99M as of Q3 2013.
  • Winchester Group sold 37,250 AbbVie shares in Q3 2013, an estimated $1.65M.
  • AbbVie made up 0.44% of Winchester Group's portfolio in Q3 2013, its #65 holding.
  • Winchester Group first reported a position in AbbVie in Q2 2013 and has held it in 2 quarters since.
  • Winchester Group's AbbVie position peaked at $3.38M in Q2 2013.
  • 1,297 funds tracked by Wall St. Rank held AbbVie as of Q3 2013.

Based on Winchester Group's 13F filing for Q3 2013, filed 16 Oct 2013.